Bide Pharmatech Management
Management criteria checks 0/4
Bide Pharmatech's CEO is Lan Dai, appointed in Oct 2023, has a tenure of 1.33 years. directly owns 33.58% of the company’s shares, worth CN¥1.44B. The average tenure of the management team and the board of directors is 1.3 years and 1.3 years respectively.
Key information
Lan Dai
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.3yrs |
| CEO ownership | 33.6% |
| Management average tenure | 1.3yrs |
| Board average tenure | 1.3yrs |
Recent management updates
Recent updates
CEO
Lan Dai (52 yo)
1.3yrs
Tenure
Ms. Lan Dai is GM & Chairman of Bide Pharmatech Co. Ltd. from October 13, 2023. Ms. Dai was Director of Bide Pharmatech Co. Ltd.from October 17, 2020 to October 13, 2023.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 1.3yrs | no data | 33.58% CN¥ 1.4b | |
| Secretary of the Board | 5.3yrs | CN¥982.10k | no data | |
| Deputy GM & Director | no data | CN¥928.00k | no data | |
| Assistant to GM & Director | 1.3yrs | CN¥898.00k | no data | |
| Senior Product Manager | no data | no data | no data |
1.3yrs
Average Tenure
41yo
Average Age
Experienced Management: 688073's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 4.3yrs | no data | 33.58% CN¥ 1.4b | |
| Secretary of the Board | 1.3yrs | CN¥982.10k | no data | |
| Deputy GM & Director | 4.3yrs | CN¥928.00k | no data | |
| Assistant to GM & Director | 1.3yrs | CN¥898.00k | no data | |
| Independent Director | 1.3yrs | CN¥19.40k | no data | |
| Supervisor | 4.3yrs | no data | no data | |
| R&D Director and Supervisor | 4.3yrs | CN¥549.90k | no data | |
| Independent Director | 1.3yrs | CN¥19.40k | no data | |
| Independent Director | 1.3yrs | CN¥19.40k | no data | |
| Brand Senior Director & Supervisor | 1.3yrs | CN¥712.60k | no data |
1.3yrs
Average Tenure
42.5yo
Average Age
Experienced Board: 688073's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/04 08:55 |
| End of Day Share Price | 2025/01/13 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bide Pharmatech Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| Kai Wang | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |